Innovation
New: Operationalising Value Based Pricing
11 August 2011
To date, the UK Government has not been specific about how VBP will be implemented, but has indicated that calculations of value will extend beyond the…
Previews of Forthcoming Publications
27 July 2011
OHE is making available as Occasional Papers drafts of two important chapters that will appear in the Oxford Handbook on the Economics of the Pharmaceutical Industry…
News Release: Fighting Superbugs
6 July 2011
A new report today by the Office of Health Economics (OHE) called for a shake up in the way future antibiotics are to be rewarded in…
Drugs and Vaccines for Developing Countries
1 June 2011
Forthcoming in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, this paper describes the context of the problem of access to medicines in developing…
Measuring Value with Pharmacoeconomics
26 May 2011
In forthcoming chapter in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, experts in the field outline the evolution of cost-effectiveness analysis (CEA) through…
Incorporating Multiple Criteria in HTA
19 April 2011
This OHE publication is intended to inform and stimulate debate about the way different sorts of evidence and considerations are taken into account in decisions about…
New: Antimicrobial Drug Incentives
6 April 2011
Antimicrobial resistance (AMR) is becoming a major global public health threat. In this new OHE Research Paper, the authors identify barriers to the development of new…
Value-Based Pricing: OHE Comments
23 March 2011
In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which…
Differential Pricing – A Win-Win Solution?
2 March 2011
Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects…